During the past decade, Veterans Adminstration New Jersey Health Care System conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 43 clinical trials were completed, i.e. on average, 330.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 23 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Veterans Adminstration New Jersey Health Care System" #1 sponsor was "National Cancer Institute (NCI)" with 31 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Agouron Pharmaceuticals" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Veterans Adminstration New Jersey Health Care System" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Veterans Adminstration New Jersey Health Care System" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "HIV Infections" (5 trials), "Prostate Cancer" (4 trials) and "Recurrent Melanoma" (4 trials). Many other conditions were trialed in "Veterans Adminstration New Jersey Health Care System" in a lesser frequency.

Most popular intervention types in "Veterans Adminstration New Jersey Health Care System" are "Drug" (55 trials), "Other" (38 trials), "Biological" (25 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Quality-of-Life Assessment" (9 trials), "Bevacizumab" (7 trials), "Docetaxel" (6 trials) and "Lenalidomide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Veterans Adminstration New Jersey Health Care System" are 56 trials for "All" genders, 6 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Veterans Adminstration New Jersey Health Care System". undefined are not yet recruiting, 1 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Veterans Adminstration New Jersey Health Care System, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Veterans Adminstration New Jersey Health Care System, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".